Sulzer Changes Name To Centerpulse, Will Approve Class Settlement May 22
This article was originally published in The Gray Sheet
Executive Summary
Sulzer Medica will attempt to reduce the financial impact of 132 opt-out cases from its class action settlement, reiterating that the firm may file for Chapter 11 bankruptcy to avoid settling those claims
You may also be interested in...
Zimmer Contacting Physicians Over Hip Implant Fracture Reports In Europe
Zimmer has sent "Dear Doctor" letters to orthopedic surgeons who have used the firm's ZMR hip stem prostheses after several reports of implant fractures
Zimmer Contacting Physicians Over Hip Implant Fracture Reports In Europe
Zimmer has sent "Dear Doctor" letters to orthopedic surgeons who have used the firm's ZMR hip stem prostheses after several reports of implant fractures
Financings In Brief
LipoScience IPO: Sale of 5 mil. shares in $80 mil. initial public offering is postponed Sept. 19. The maker of the NMR LipoProfile cardiovascular disease risk assessment test planned on pricing each share at $14-16 (1"The Gray Sheet" March 11, 2002, p. 18). The IPO, which originally had been targeted to raise $100 mil., was delayed following the stock market downturn the week of Sept. 16. The NMR LipoProfile is more expensive than traditional, standard-of-care cholesterol tests, which may have contributed to investor jitters...